BackMedifast Overview

Medifast Accounts Payable

Track Medifast's accounts payable ($36M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$36.41M
9.57% YoYΔ $-3.85M vs prior year quarter

Peer trimmed avg / median

Loading

Medifast Accounts Payable History

Loading

Medifast vs. peers: Accounts Payable Comparison

Loading

Medifast Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Medifast (MED) FAQ

As of the most recent data (June 2026), MED shows a accounts payable of $36M. That compares with $40M in the prior-year period — down 9.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MED's accounts payable is now $36M (was $40M) — a 9.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Medifast is outperforming or lagging.

Tracking MED's accounts payable over time shows whether Medifast is scaling, shrinking, or reshaping that part of the business. The current reading is $36M That compares with $40M in the prior-year period — down 9.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Medifast's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $36M) with ownership activity and broader fundamentals.

Medifast's accounts payable is $36M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.